In 2024, Medicare will, for the first time, have authority under the Inflation Reduction Act passed in 2022 to negotiate drug prices with pharmaceutical manufacturers. On August 29, the Centers for Medicare and Medicaid...more
9/5/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Constitutional Challenges ,
Drug Pricing ,
Eighth Amendment ,
Fifth Amendment ,
First Amendment ,
Free Speech ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Inflation Reduction Act (IRA) ,
Manufacturers ,
Medicare ,
Medicare Part D ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Takings